Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) is an international, pediatric and adult registry to monitor and report on outcomes of coronavirus (COVID-19) occurring in inflammatory bowel disease (IBD) patients. 

This study asks for doctors to report cases of coronavirus amongst their IBD patients, rather than asking for patients to give their input directly. You can speak to your doctor to see if they're taking part. You can find out more information in this flyer for the study or on their website.

How can a doctor report a case?  All IBD doctors can report all cases of confirmed COVID-19 in IBD patients, regardless of severity. Reporting should take at most 5 minutes, but they should only report confirmed COVID-19 cases. They should then report after a minimum of 7 days from COVID diagnosis and sufficient time has passed to report on the outcomes of the patient. To report a case of coronavirus, click here.

When will the findings of this work come out?  Findings should be reported in early 2021. Preliminary data can be found on their website, but please remember that only a small number of people have reported so far and they have not yet been checked and verified, so we can't read too much into this data yet.

Lead Researchers: This project is being led by Drs. Michael Kappelman (Pediatric Gastroenterologist) and Erica Brenner (Pediatric Gastroenterology fellow) at the University of North Carolina at Chapel Hill and Dr. Ryan Ungaro (Gastroenterologist), Dr. Manasi Agrawal (Gastroenterologist) and Dr. Jean-Frederic Colombel (Gastroenterologist) at the Icahn School of Medicine at Mount Sinai, New York.

Please note that the registry contains only de-identified data, in accordance with HIPAA Safe Harbor De-Identification standards. The UNC-Chapel Hill Office for Human Research Ethics has determined that storage and analysis of de-identified data does not constitute human subjects research and so does not require IRB ethical approval.

This research study is NOT funded or organised by Crohn's & Colitis UK and, therefore, we cannot take responsibility for your involvement in the research. It is a patient’s choice to take part.